Flexeril and Naproxen sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Naproxen sodium (naproxen sodium). Common drug interactions include nasopharyngitis among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Flexeril and Naproxen sodium. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.

What is Naproxen sodium?

Naproxen sodium has active ingredients of naproxen sodium. It is often used in pain. eHealthMe is studying from 11,252 Naproxen sodium users. Check the latest studies of Naproxen sodium.



On Jul, 06, 2026

100 people who take Flexeril and Naproxen sodium together, and have interactions are studied.

Flexeril and Naproxen sodium drug interactions.

What are the common drug interactions of Flexeril and Naproxen Sodium, by gender? *:

female:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Weight increased
  3. Anaemia (lack of blood)
  4. Blood glucose increased
  5. Chest pain
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Cold sweat
  8. Ingrowing nail
  9. Injury
  10. Joint swelling

male:

  1. Vomiting
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Exostosis (formation of new bone on the surface of a bone)
  4. Joint injury
  5. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  6. Nerve compression
  7. Polyarthritis (arthritis which involves 5 or more joints simultaneously)
  8. Spinal osteoarthritis (joint cartilage loss in spine)
  9. Asthenia (weakness)
  10. Cardiac failure congestive

What are the common drug interactions of Flexeril and Naproxen Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anxiety
  2. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  3. Head injury
  4. Headache (pain in head)
  5. Infusion related reaction
  6. Nausea (feeling of having an urge to vomit)
  7. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Vomiting

20-29:

  1. Arthralgia (joint pain)
  2. Cellulitis (infection under the skin)
  3. Cold sweat
  4. Dizziness
  5. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Ingrowing nail
  8. Injury
  9. Mitral valve incompetence (inefficient heart valve)
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

30-39:

  1. Alanine aminotransferase increased
  2. Diarrhoea
  3. Dehydration (dryness resulting from the removal of water)
  4. Urinary tract infection
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Decreased activity
  7. Dizziness
  8. Fasciitis (infection of muscle surrounding tissue)
  9. Fibromyalgia (a long-term condition which causes pain all over the body)
  10. Hunger

40-49:

  1. Anxiety
  2. Upper respiratory tract infection
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Fatigue (feeling of tiredness)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Alopecia (absence of hair from areas of the body)
  7. Arthralgia (joint pain)
  8. Depression
  9. Drug hypersensitivity
  10. Gait disturbance

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Peripheral swelling
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Therapeutic response unexpected
  5. Abdominal discomfort
  6. Back injury
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)
  9. Nerve compression
  10. Alanine aminotransferase increased

60+:

  1. Vomiting
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Aphagia (inability or refusal to swallow)
  4. Exostosis (formation of new bone on the surface of a bone)
  5. Joint injury
  6. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  7. Nerve compression
  8. Polyarthritis (arthritis which involves 5 or more joints simultaneously)
  9. Asthenia (weakness)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 22 people, 22.00%
  2. Depression: 15 people, 15.00%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 14 people, 14.00%
  4. Stress And Anxiety: 13 people, 13.00%
  5. High Blood Pressure: 10 people, 10.00%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 7.00%
  7. High Blood Cholesterol: 6 people, 6.00%
  8. Headache (pain in head): 6 people, 6.00%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 6.00%
  10. Diabetes: 6 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and Naproxen sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flexeril and Naproxen sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naproxen sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naproxen sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and naproxen sodium (the active ingredients of Flexeril and Naproxen sodium, respectively), and Flexeril and Naproxen sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: